Fundraising Fox

First In Ventures β€” Full Portfolio

28 tracked investments Β· listed companies and verified rows first

Humacytehumacyte.comin𝕏NASDAQ: HUMA

Humacyte is a regenerative medicine company that develops a bioengineered, human-derived Acellular Tissue Engineered Vessel (ATEV) along with a scalable cell sourcing and manufacturing platform.

BiotechHealthtechMedical DevicesMorrisville, US

Laura E. Niklason(Director)inLaura Niklason, MD, PhD(Founder)inTed Lithgow(Executive Officer)inPaul Boyer(Executive Officer)inCarrie S. Cox(Executive Officer, Director)

BoardRobert Anderson(Director)

Co-investorsFresenius Medical Care VenturesOberland Capital

Pluton Biosciencesplutonbio.cominβœ“ verified

Pluton is developing a sun-powered, soil-surface biological nutrient system that uses photosynthetic microbial consortia to fix atmospheric nitrogen, improve phosphorus availability, and add carbon to soil for crop growers.

AgTechBiotechClimate TechSt. Louis, US

Barry Goldman(Co-founder)inElizabeth Gallegos(Chief Executive Officer)inJerry Steiner(Executive Chair)inCharlie Walch(Executive Officer, Director)Glendon Schuster(Director)

Co-investorsIllumina VenturesRadicle GrowthBetter VenturesFall Line CapitalGrantham FoundationRA Capital+4 more

Gliknikgliknik.comJun 2023

Baltimore-based immunology company focused on treatments for cancer and autoimmune disorders; raised an $11.5 million Series C led by First In Ventures.

BiotechBaltimore, US

David S. Block(Executive Officer, Director)Elizabeth C. Block(Executive Officer)Raymond Shinazi(Director)Joseph Klein(Director)Mark Lerner(Director)

BoardCharles Polsky(Director)

Board seatKyle RusconiΒ· per SEC Form D

Co-investorsBrace Pharma

4BaseCare4basecare.comin

4baseCare delivers personalized cancer care using genomic data, AI analytics, and clinico-genomic datasets tailored to different populations.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Hitesh Goswami(Founder/CEO)inKshitij Rishi(COO)inPuneet Pantane(CDO)inDr. Giridharan Periyasamy

Co-investorsMerak VenturesMount Judi VenturesSeason Two VenturesYali Capital

Aarogyaaarogya.ai
Adluminadlumin.comin𝕏Nov 2023 Β· $70M

N-able delivers unified cybersecurity and data protection solutions including endpoint management (N-central), AI-powered threat detection and response (Adlumin), and disaster recovery services (Cove).

AI & Machine LearningCloud ComputingCybersecurityEnterprise SoftwareAlexandria, US

Robert S. Jonhston(Executive Officer, Director)

Co-investorsBankTech VenturesSyn Ventures Seed Management LlcFirst InLeawood Venture Capital LlcSYN Ventures

Biotaxbiotax.coin

EcoBiotaX develops a microbial ecology platform that uses AI (its ecoSat computational platform) and biological methods to discover and construct natural bacterial communities for specific biological functions.

AgTechAI & Machine LearningBiotech

Naama Geva-Zatorsky(Co-Founder)inShay Hilel(Co-Founder & CEO)inDean Light(Co-Founder & CTO)in

Co-investorsZORA

Broken String Biosciencesbrokenstringbio.comin

Broken String Biosciences develops tools for genome-wide on- and off-target analysis in gene editing, enabling in-house detection and characterization of gene editing-induced DNA breaks.

AI & Machine LearningBiotechDeep Tech

Co-investorsHeran PartnersIllumina VenturesKorysMΓ©rieux Equity Partners

Celldomcelldom.comin

CellDom develops CloneXplorer, a live single-cell assay platform combining functional imaging, molecular readouts, and integrated cell retrieval for high-resolution cell analysis.

BiotechDeep TechHardwareMedical Devices

Co-investorsTSVC

Cognitivegeneticscognitivegenetics.com
Doloromicsdoloromics.com
Epicombiepicombi.ai
Felix Biotechnologyfelixbt.comin𝕏Defunct

Felix Biotechnology develops a digital platform for designing viruses intended to combat antimicrobial resistance.

BiotechHealthtechSan Francisco, US

Robert McBride(Founder)inVivek Mutalik(Founder)inPaul Turner(Founder)in

Co-investorsPoint72 VenturesY Combinator

Flightpathflightpath.bioin

Flightpath Biosciences develops microbiome-sparing, pathogen-specific drug candidates to treat infection-associated diseases by selectively targeting harmful bacteria while preserving healthy microbial communities.

BiotechDeep TechDigital HealthHealthtechMedical Devices

Matt Tindall(Founder)in

Co-investorsID VenturesMichigan Rise

Futuragenomicsfuturagenomics.com

Futura Genomics provides accredited genetic testing services that deliver personalized health and ancestry insights tailored to diverse populations, with particular focus on African heritage.

BiotechConsumerDigital HealthHealthtech

Lassogenlassogen.comin𝕏Sep 2020

Lassogen engineers lasso peptides β€” structurally unique 3D scaffolds β€” into therapeutics it calls Lassotides, designed to combine the strengths of antibodies and small molecules.

AI & Machine LearningBiotechSan Diego, US

Mark J Burk(Executive Officer)

Co-investorsBetter Ventures Central LlcPlayground Global

Lightspeedbiolightspeedbio.comin𝕏

Alpenglow Biosciences develops the Aurora 3D spatial biology platform, combining open-top light-sheet microscopy, volumetric data processing, and AI analysis to turn intact tissue into quantitative 3D data.

AI & Machine LearningBiotechMedical Devices

Mabletrymable.comin𝕏Jul 2022 Β· $3.2MAcquired

Mable is a genomics-based telehealth platform that provides personalized migraine care by analyzing patients' genetic and biomarker data to inform individualized treatment plans.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon, GB

Roman Rothaermel(Founder)inInna Thalmann(Founder)inChris EijsboutsinKumeren Govnder

Co-investorsInitialized CapitalUnderscore VCVenrockY CombinatorArkitekt Ventures

Medic Life Sciencesmedic-life-sciences.com

Medic Life Sciences applies CRISPR functional genomics in 3D patient tumor-like cancer models to identify biomarkers, synthetic lethality, and resistance mutations for oncology drug development.

BiotechDeep TechHealthtech

Kyuho Han(Chief Executive Officer/Co-Founder)Hong-Pyo Lee(Chief Technology Officer/Co-Founder)

Co-investorsSazze

Mitra Biomitrabio.techin𝕏

Mitra develops a non-invasive skin diagnostics platform that combines clinical trials, skin sampling, next-generation sequencing, and data science to guide the design of age-rejuvenating skincare compounds.

BiotechDeep TechDigital HealthHealthtechLongevityMedical DevicesLondon, GB

Shakiba Kaveh(CEO)inCristiana Banila(CTO)in

Co-investorsEntrepreneur FirstMerian Ventures

Multiplaihealthmultiplaihealth.comin𝕏

MultiplAI Health is developing an RNA-sequencing and AI-based whole blood screening test to detect complex diseases, with a focus on cardiovascular disorders and cancer.

AI & Machine LearningBiotechDigital Health

Neurolytic Healthcareneurolytic-healthcare.comDec 2021

HealthtechLondon

Roman Rothaermel(Executive Officer, Director, Promoter)Tom Kent(Executive Officer, Director, Promoter)Inna Thalmann(Executive Officer, Director, Promoter)Parul Singh(Director)

Parallelhealthparallelhealth.ioin

Parallel Health offers a skincare product line addressing aging through microbiome science, including peptide creams and cleansers designed to target the hallmarks of skin aging.

BiotechConsumerDigital HealthDirect to ConsumerHealthtechWellness & Fitness

Nathan Brown(Founder)in

Co-investorsAxial VCHyphen Capital

Prenome

Startup developing a way to help pregnant women predict and manage gestational diabetes; participated in TechCrunch Disrupt Startup Battlefield.

Stempharmstempharm.comin𝕏

Stem Pharm develops therapeutics using stem cell technology for disease treatment and drug discovery.

BiotechDeep TechHealthtechMedical DevicesNew MaterialsMadison, US

Connie Lebakken(COO)inBill Murphy(CSO)inSteven Visuri(CEO)inRyan Gordon(Sr. V.P. of Business Development and Commercialization)in

Tailortailor.bioin

Tailor Bio develops targeted cancer therapies for tumors characterized by chromosomal instability, working in the field of precision oncology.

BiotechHealthtech

Wellsimbiotechwellsimbiotech.com
Yali Bioyalibio.cominFeb 2022 Β· $3.9M

Yali develops fermentation technology to produce sustainable fats and lipids for alternative dairy products like ice cream, butter, and milk, using fewer inputs than conventional sources.

BiotechCleantechClimate TechFoodTech

Co-investorsFTW VenturesS2G InvestmentsCRCM VenturesThird Kind Venture Capital

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.